Cargando…
How Did We End Up Using a Quadruple Guided Therapy Combining At Least Two Antibiotics with a PPI to Eradicate Helicobacter pylori?
Autores principales: | Pichon, Maxime, Cremniter, Julie, Burucoa, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457093/ https://www.ncbi.nlm.nih.gov/pubmed/36079146 http://dx.doi.org/10.3390/jcm11175216 |
Ejemplares similares
-
Mutations Associated to Antibiotic-Resistant Helicobacter pylori: It Is Time to Validate Sequencing Observations
por: Pichon, Maxime, et al.
Publicado: (2022) -
French national epidemiology of bacterial superinfections in ventilator-associated pneumonia in patients infected with COVID-19: the COVAP study
por: Pichon, Maxime, et al.
Publicado: (2023) -
Where to Biopsy to Detect Helicobacter pylori and How Many Biopsies Are Needed to Detect Antibiotic Resistance in a Human Stomach
por: Pichon, Maxime, et al.
Publicado: (2020) -
Guided Treatment of Helicobacter pylori Infections with Non-Invasive PCR Tests—The Glory Days of Primary Care?
por: Pichon, Maxime, et al.
Publicado: (2022) -
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
por: Gisbert, Javier P, et al.
Publicado: (2012)